Differential activation of inflammatory pathways in A549 type II pneumocytes by Streptococcus pneumoniae strains with different adherence properties

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Robson, Rachel L ^a   Reed, Natalie A ^a   Horvat, Rebecca T ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; BINDING PROTEIN; CHOLINE; COMPLEMENT COMPONENT C3; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PNEUMOCOCCUS VACCINE;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LOBAR PNEUMONIA; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; MAJOR CLINICAL STUDY; NONHUMAN; PROTEIN MICROARRAY; RECEPTOR BLOCKING; STREPTOCOCCUS PNEUMONIAE; WESTERN BLOTTING;

BACTERIAL ADHESION; CELL LINE; HUMANS; INFLAMMATION; INTERLEUKIN-8; NF-KAPPA B; PNEUMONIA, PNEUMOCOCCAL; PULMONARY ALVEOLI; STREPTOCOCCUS PNEUMONIAE;

EID: 33745674693     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-71     Document Type: Article

References (44)

1. File TM: Community-acquired pneumonia. Lancet 2003, 362:1991-2001.
2. File TMJ: Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern. Am J Med 2004, 117 Suppl 3A:39S-50S.
3. Austrian R: Some aspects of the pneumococcal carrier state. J Antimicrob Chemother 1986, 18 Suppl A:35-45.
4. Hendley JO, Sande MA, Stewart PM, Gwaltney JMJ: Spread of Streptococcus pneumoniae in families. I. Carriage rates and distribution of types. J Infect Dis 1975, 132:55-61.
5. Cockeran R, Anderson R, Feldman C: Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease. Arch Immunol Ther Exp (Warsz) 2005, 53:189-198.
6. Jedrzejas MJ: Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 2001, 65:187-207.
7. Jedrzejas MJ: Extracellular virulence factors of Streptococcus pneumoniae. Front Biosci 2004, 9:891-914.
8. Polissi A, Pontiggia A, Feger G, Altieri M, Mottl H, Ferrari L, Simon D: Large-scale identification of virulence genes from Streptococcus pneumoniae. Infect Immun 1998, 66:5620-5629.
9. Varon E: [Severe pneumococcal infections: virulence aspects]. Arch Pediatr 2001, 8 Suppl 4:752s-756s.
10. Bogaert D, de Groot R, Hermans PW: Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
11. Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C: Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am Rev Respir Dis 1986, 134:1040-1044.
12. Cundell DR, Weiser JN, Shen J, Young A, Tuomanen El: Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun 1995, 63:757-761.
13. Talbot UM, Paton AW, Paton JC: Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun 1996, 64:3772-3777.
14. McCullers JA, Tuomanen El: Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 2001, 6:D877-D889.
15. Brown PD, Lerner SA: Community-acquired pneumonia. Lancet 1998, 352:1295-1302.
16. Novak R, Tuomanen E: Pathogenesis of pneumococcal pneumonia. Semin Respir Infect 1999, 14:209-217.
17. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen El: Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995, 377:435-438.
18. Hermoso JA, Lagartera L, Gonzalez A, Stelter M, Garcia P, Martinez-Ripoll M, Garcia JL, Menendez M: Insights into pneumococcal pathogenesis from the crystal structure of the modular teichoic acid phosphorylcholine esterase Pce. Nat Struct Mol Biol 2005, 12:533-538.
19. Shani-Sekler M, Lifshitz S, Hillel I, Dagan R, Grossman N, Fleminger G, Mizrachi-Brauner Y: Initial steps in Streptococcus pneumoniae interaction with and pathogenicity to the host. Adv Exp Med Biol 2000, 479:61-71.
20. Madsen M, Lebenthal Y, Cheng Q, Smith BL, Hostetter MK: A pneumococcal protein that elicits interleukin-8 from pulmonary epithelial cells. J Infect Dis 2000, 181:1330-1336.
21. Rosenow C, Ryan P, Weiser JN, Johnson S, Fontan P, Ortqvist A, Masure HR: Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 1997, 25:819-829.
22. Smith BL, Hostetter MK: C3 as substrate for adhesion of Streptococcus pneumoniae. J Infect Dis 2000, 182:497-508.
23. Murdoch C, Read RC, Zhang Q, Finn A: Choline-binding protein A of Streptococcus pneumoniae elicits chemokine production and expression of intercellular adhesion molecule I (CD54) by human alveolar epithelial cells. J Infect Dis 2002, 186:1253-1260.
24. Strunk RC, Eidlen DM, Mason RJ: Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J Clin Invest 1988, 81:1419-1426.
25. Brooks-Walter A, Briles DE, Hollingshead SK: The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 1999, 67:6533-6542.
26. Lefevre JC, Faucon G, Sicard AM, Gasc AM: DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J Clin Microbiol 1993, 31:2724-2728.
27. Arai S, Konda T, Wad A, Matsunaga Y, Okabe N, Watanabe H, Inouye S: Use of antiserum-coated latex particles for serotyping Streptococcus pneumoniae. Microbiol Immunol 2001, 45:159-162.
28. Briese T, Hakenbeck R. Interaction of the pneumococcal amidase with lipoteichoic acid and choline. Eur J Biochem 1985, 146:417-427.
29. Cundell DR, Gerard C, Idanpaan-Heikkila I, Tuomanen EI, Gerard NP: PAf receptor anchors Streptococcus pneumoniae to activated human endothelial cells. Adv Exp Med Biol 1996, 416:89-94.
30. Elm C, Rohde M, Vaerman JP, Chhatwal GS, Hammerschmidt S: Characterization of the interaction of the pneumococcal surface protein SpsA with the human polymeric immunoglobulin receptor (hplgR). Indian J Med Res 2004, 119 Suppl:61-65.
31. Centers for Disease Control and Prevention: Streptococcus pneumoniae Disease. Available at: http://www.cdcgov/ncidod/dbmd/diseaseinfo/ streppneum_thtm.5 AD
32. Kelly T, Dillard JP, Yother J: Effect of genetic switching of capsular type on virulence of Streptococcus pneumoniae. Infect Immun 1994, 62:1813-1819.
33. Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T: Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004, 4:21.
34. Zhang JR, Mostov KE, Lamm ME, Nanno M, Shimida S, Ohwaki M, Tuomanen E: The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells. Cell 2000, 102:827-837.
35. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI: Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis 2004, 190:1661-1669.
36. Berry AM, Paton JC: Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 2000, 68:133-140.
37. Weiser JN, Austrian R, Sreenivasan PK, Masure HR: Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 1994, 62:2582-2589.
38. Kim JO, Weiser JN: Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis 1998, 177:368-377.
39. McCool TL, Cate TR, Tuomanen EI, Adrian P, Mitchell TJ, Weiser JN: Serum immunoglobulin G response to candidate vaccine antigens during experimental human pneumococcal colonization. Infect Immun 2003, 71:5724-5732.
40. Ogunniyi AD, Woodrow MC, Poolman JT, Paton JC: Protection against Streptococcus pneumoniae elicited by immunization with pneumolysin and CbpA. Infect Immun 2001, 69:5997-6003.
41. Zhang Q, Bernatoniene J, Bagrade L, Pollard AJ, Mitchell TJ, Paton JC, Finn A: Serum and mucosal antibody responses to pneumococcal protein antigens in children:relationships with carriage status. Eur J Immunol 2006, 36:46-57.
42. Jones MP, Simms BT, Lupa MM, Kogan MS, Mizgerd JP: Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J Immunol 2005, 175:7530-7535.
43. Sadikot RT, Han W, Everhart MB, Zoia O, Peebles RS, Jansen ED, Yull FE, Christman JW, Blackwell TS: Selective I kappa B kinase expression in airway epithelium generates neutrophilic lung inflammation. J Immunol 2003, 170:1091-1098.
44. Stockley RA: Role of inflammation in respiratory tract infections. Am J Med 1995, 99:8S-13S.